🇺🇸 FDA
Patent

US 7754714

Cycloalkyl substituted pyrimidinediamine compounds and their uses

granted A61KA61K31/505A61K31/506

Quick answer

US patent 7754714 (Cycloalkyl substituted pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/505, A61K31/506, A61P, A61P1/04